105 related articles for article (PubMed ID: 1310401)
1. Increased sensitivity of an adriamycin-resistant human small cell lung carcinoma cell line to mitochondrial inhibitors.
de Jong S; Holtrop M; de Vries H; de Vries EG; Mulder NH
Biochem Biophys Res Commun; 1992 Jan; 182(2):877-85. PubMed ID: 1310401
[TBL] [Abstract][Full Text] [Related]
2. NMR spectroscopy analysis of phosphorus metabolites and the effect of adriamycin on these metabolite levels in an adriamycin-sensitive and -resistant human small cell lung carcinoma cell line.
de Jong S; Mulder NH; de Vries EG; Robillard GT
Br J Cancer; 1991 Feb; 63(2):205-12. PubMed ID: 1847646
[TBL] [Abstract][Full Text] [Related]
3. Reduced DNA topoisomerase II activity and drug-induced DNA cleavage activity in an adriamycin-resistant human small cell lung carcinoma cell line.
de Jong S; Zijlstra JG; de Vries EG; Mulder NH
Cancer Res; 1990 Jan; 50(2):304-9. PubMed ID: 1967222
[TBL] [Abstract][Full Text] [Related]
4. Topoisomerase II as a target of VM-26 and 4'-(9-acridinylamino)methanesulfon-m-aniside in atypical multidrug resistant human small cell lung carcinoma cells.
de Jong S; Kooistra AJ; de Vries EG; Mulder NH; Zijlstra JG
Cancer Res; 1993 Mar; 53(5):1064-71. PubMed ID: 8382551
[TBL] [Abstract][Full Text] [Related]
5. Effects of amiodarone, cyclosporin A, and PSC 833 on the cytotoxicity of mitoxantrone, doxorubicin, and vincristine in non-P-glycoprotein human small cell lung cancer cell lines.
van der Graaf WT; de Vries EG; Timmer-Bosscha H; Meersma GJ; Mesander G; Vellenga E; Mulder NH
Cancer Res; 1994 Oct; 54(20):5368-73. PubMed ID: 7923167
[TBL] [Abstract][Full Text] [Related]
6. Energy-dependent processes involved in reduced drug accumulation in multidrug-resistant human lung cancer cell lines without P-glycoprotein expression.
Versantvoort CH; Broxterman HJ; Pinedo HM; de Vries EG; Feller N; Kuiper CM; Lankelma J
Cancer Res; 1992 Jan; 52(1):17-23. PubMed ID: 1309222
[TBL] [Abstract][Full Text] [Related]
7. Role of free radicals in an adriamycin-resistant human small cell lung cancer cell line.
Meijer C; Mulder NH; Timmer-Bosscha H; Zijlstra JG; de Vries EG
Cancer Res; 1987 Sep; 47(17):4613-7. PubMed ID: 3040227
[TBL] [Abstract][Full Text] [Related]
8. Multifactorial drug resistance in an adriamycin-resistant human small cell lung carcinoma cell line.
Zijlstra JG; de Vries EG; Mulder NH
Cancer Res; 1987 Apr; 47(7):1780-4. PubMed ID: 3028613
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial function and energy metabolism in neuronal HT22 cells resistant to oxidative stress.
Pfeiffer A; Jaeckel M; Lewerenz J; Noack R; Pouya A; Schacht T; Hoffmann C; Winter J; Schweiger S; Schäfer MK; Methner A
Br J Pharmacol; 2014 Apr; 171(8):2147-58. PubMed ID: 24319993
[TBL] [Abstract][Full Text] [Related]
10. Rhodamine B as a mitochondrial probe for measurement and monitoring of mitochondrial membrane potential in drug-sensitive and -resistant cells.
Reungpatthanaphong P; Dechsupa S; Meesungnoen J; Loetchutinat C; Mankhetkorn S
J Biochem Biophys Methods; 2003 Jul; 57(1):1-16. PubMed ID: 12834959
[TBL] [Abstract][Full Text] [Related]
11. Bcl-x
Pfeiffer A; Schneider J; Bueno D; Dolga A; Voss TD; Lewerenz J; Wüllner V; Methner A
Free Radic Biol Med; 2017 Nov; 112():350-359. PubMed ID: 28807815
[TBL] [Abstract][Full Text] [Related]
12. [Modulation of human small cell lung cancer cell line GLC4/ADR multidrug resistance in the inhibition of multidrug resistance-associated protein and its antisense].
Peng X; Feng F; Zhang W
Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):355-8. PubMed ID: 11810759
[TBL] [Abstract][Full Text] [Related]
13. Energy metabolism determines the sensitivity of human hepatocellular carcinoma cells to mitochondrial inhibitors and biguanide drugs.
Hsu CC; Wu LC; Hsia CY; Yin PH; Chi CW; Yeh TS; Lee HC
Oncol Rep; 2015 Sep; 34(3):1620-8. PubMed ID: 26133123
[TBL] [Abstract][Full Text] [Related]
14. Effects of c-myc oncogene modulation on drug resistance in human small cell lung carcinoma cell lines.
Van Waardenburg RC; Prins J; Meijer C; Uges DR; De Vries EG; Mulder NH
Anticancer Res; 1996; 16(4A):1963-70. PubMed ID: 8712728
[TBL] [Abstract][Full Text] [Related]
15. Effect of the local anesthetic bupivacaine on the energy metabolism of Ehrlich ascites tumor cells.
Floridi A; Barbieri R; Pulselli R; Fanciulli M; Arcuri E
Oncol Res; 1994; 6(12):593-601. PubMed ID: 7787252
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo modulation of multi-drug resistance with amiodarone.
van der Graaf WT; de Vries EG; Uges DR; Nanninga AG; Meijer C; Vellenga E; Mulder PO; Mulder NH
Int J Cancer; 1991 Jun; 48(4):616-22. PubMed ID: 1646180
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms for high methoxymorpholino doxorubicin cytotoxicity in doxorubicin-resistant tumor cell lines.
Bakker M; Renes J; Groenhuijzen A; Visser P; Timmer-Bosscha H; Müller M; Groen HJ; Smit EF; de Vries EG
Int J Cancer; 1997 Nov; 73(3):362-6. PubMed ID: 9359483
[TBL] [Abstract][Full Text] [Related]
18. Energy metabolism of adriamycin-sensitive and -resistant Ehrlich ascites tumor cells.
Miccadei S; Fanciulli M; Bruno T; Paggi MG; Floridi A
Oncol Res; 1996; 8(1):27-35. PubMed ID: 8704284
[TBL] [Abstract][Full Text] [Related]
19. The role of methoxymorpholino anthracycline and cyanomorpholino anthracycline in a sensitive small-cell lung-cancer cell line and its multidrug-resistant but P-glycoprotein-negative and cisplatin-resistant counterparts.
van der Graaf WT; Mulder NH; Meijer C; de Vries EG
Cancer Chemother Pharmacol; 1995; 35(4):345-8. PubMed ID: 7828280
[TBL] [Abstract][Full Text] [Related]
20. Modifications of oxido-reductase activities in adriamycin-resistant leukaemia K562 cells.
Denis-Gay M; Petit JM; Mazat JP; Ratinaud MH
Biochem Pharmacol; 1998 Aug; 56(4):451-7. PubMed ID: 9763220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
